Media Release
-
Gross profit increased by 10.5% to $105.2 million in H1 FY24 compared to H1 FY23.
-
EBITDA rose by 40.6% to $27.3 million in H1 FY24, with EBITDA margin improving by 5.6 percentage points to 26%.
-
Free cash flow significantly increased to $10.4 million in H1 FY24, up 17.8 times from H1 FY23.
-
Transaction value grew by 2.2% to $22.2 billion in H1 FY24.
-
Tyro Health recorded a 24% increase in transaction value and a 31% increase in customers in H1 FY24.
-
Operational efficiency and growth in non-discretionary verticals like health and services were key drivers of financial results.
-
Nearly one in five new customers signed up for Tyro’s integrated payments and banking products in H1 FY24.
-
Tyro is innovating with new payments and banking features, including multi-account settlement times and a virtual debit card, to be launched by June.
-
The company is confident in its business resilience and growth opportunities despite the macroeconomic environment.
-
FY24 financial guidance includes a transaction value of $43 billion to $44 billion, gross profit of $208 million to $215 million, and EBITDA of $54 million to $58 million, with a targeted EBITDA margin of ~26%.
-
Tyro aims to expand into at least one new vertical in the calendar year to diversify its customer base and continue developing cashflow solutions alongside payment services.
Leave a Reply